Security key
501575104
Kymera Therapeutics, Inc. - COMMON STOCK (KYMR)
CUSIP: 501575104
Q4 2021 13F Holders as of 31 Dec 2021
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 81,496,373
- Total 13F shares
- 43,015,870
- Share change
- +1,981,264
- Total reported value
- $2,729,867,438
- Put/Call ratio
- 3.1%
- Price per share
- $63.49
- Number of holders
- 123
- Value change
- +$128,644,677
- Number of buys
- 73
- Number of sells
- 40
Report period
Q4 2021
Institutions
123
Top holders
10
KYMR full security history
Newer quarter: Q1 2022
Previous quarter: Q3 2021
Kymera Therapeutics, Inc. SEC filings
Kymera Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 501575104
Recent filing periods:
Top shareholders of KYMR - Kymera Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
4%
|
3,233,197
|
$189,918,000 | — | 30 Sep 2021 | |
| BVF INC/IL |
13F
|
Company |
3.9%
|
3,180,658
|
$186,832,000 | — | 30 Sep 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.7%
|
3,040,431
|
$178,595,000 | — | 30 Sep 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.6%
|
2,901,574
|
$170,438,000 | — | 30 Sep 2021 | |
| Redmile Group, LLC |
13F
|
Company |
3.4%
|
2,793,708
|
$164,102,000 | — | 30 Sep 2021 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
3%
|
2,467,935
|
$144,966,000 | — | 30 Sep 2021 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
2.9%
|
2,384,742
|
$140,080,000 | — | 30 Sep 2021 | |
| FMR LLC |
13F
|
Company |
2.9%
|
2,355,807
|
$138,380,000 | — | 30 Sep 2021 | |
| STATE STREET CORP |
13F
|
Company |
1.8%
|
1,439,776
|
$84,572,000 | — | 30 Sep 2021 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.9%
|
732,927
|
$43,052,000 | — | 30 Sep 2021 | |
| AJU IB Investment Co., Ltd. |
13F
|
Company |
0.78%
|
639,059
|
$37,538,000 | — | 30 Sep 2021 | |
| Deer IX & Co. Ltd. |
13F
|
Company |
0.76%
|
615,895
|
$36,178,000 | — | 30 Sep 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.74%
|
599,870
|
$35,236,000 | — | 30 Sep 2021 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.72%
|
583,192
|
$34,257,000 | — | 30 Sep 2021 | |
| Avidity Partners Management LP |
13F
|
Company |
0.63%
|
514,500
|
$30,222,000 | — | 30 Sep 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.61%
|
500,880
|
$29,422,000 | — | 30 Sep 2021 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
0.56%
|
455,750
|
$26,771,000 | — | 30 Sep 2021 | |
| Artal Group S.A. |
13F
|
Company |
0.49%
|
400,000
|
$23,496,000 | — | 30 Sep 2021 | |
| S.c.a. Candriam |
13F
|
Individual |
0.48%
|
394,991
|
$23,201,000 | — | 30 Sep 2021 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.44%
|
359,260
|
$21,103,000 | — | 30 Sep 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.42%
|
338,723
|
$19,897,000 | — | 30 Sep 2021 | |
| CLOUGH CAPITAL PARTNERS L P |
13F
|
Company |
0.33%
|
271,000
|
$15,919,000 | — | 30 Sep 2021 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.33%
|
266,289
|
$15,641,817 | — | 30 Sep 2021 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.31%
|
250,000
|
$14,685,000 | — | 30 Sep 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.3%
|
243,225
|
$14,288,000 | — | 30 Sep 2021 | |
| WASATCH ADVISORS LP |
13F
|
Company |
0.3%
|
241,366
|
$14,178,000 | — | 30 Sep 2021 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.23%
|
184,581
|
$10,842,000 | — | 30 Sep 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.22%
|
180,207
|
$10,585,000 | — | 30 Sep 2021 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.22%
|
180,000
|
$10,573,000 | — | 30 Sep 2021 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.21%
|
174,026
|
$10,219,000 | — | 30 Sep 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.2%
|
165,935
|
$9,746,000 | — | 30 Sep 2021 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.19%
|
157,400
|
$9,246,000 | — | 30 Sep 2021 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.18%
|
150,746
|
$8,855,000 | — | 30 Sep 2021 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
0.16%
|
131,694
|
$7,736,000 | — | 30 Sep 2021 | |
| Woodline Partners LP |
13F
|
Company |
0.16%
|
129,331
|
$7,597,000 | — | 30 Sep 2021 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.15%
|
125,000
|
$7,343,000 | — | 30 Sep 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.14%
|
116,961
|
$7,363,000 | — | 30 Sep 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.14%
|
113,928
|
$6,692,000 | — | 30 Sep 2021 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.11%
|
93,049
|
$5,466,000 | — | 30 Sep 2021 | |
| Asymmetry Capital Management, L.P. |
13F
|
Company |
0.11%
|
89,071
|
$5,232,000 | — | 30 Sep 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.11%
|
87,556
|
$5,142,000 | — | 30 Sep 2021 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.08%
|
67,965
|
$3,992,000 | — | 30 Sep 2021 | |
| LMR Partners LLP |
13F
|
Company |
0.08%
|
65,941
|
$3,873,000 | — | 30 Sep 2021 | |
| Swiss National Bank |
13F
|
Company |
0.07%
|
60,500
|
$3,554,000 | — | 30 Sep 2021 | |
| NATIXIS |
13F
|
Company |
0.07%
|
56,139
|
$3,298,000 | — | 30 Sep 2021 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.07%
|
54,574
|
$3,206,000 | — | 30 Sep 2021 | |
| NORGES BANK |
13F
|
Company |
0.07%
|
54,163
|
$3,182,000 | — | 30 Sep 2021 | |
| CITIGROUP INC |
13F
|
Company |
0.07%
|
53,338
|
$3,133,000 | — | 30 Sep 2021 | |
| Laurion Capital Management LP |
13F
|
Company |
0.06%
|
48,987
|
$2,877,000 | — | 30 Sep 2021 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.06%
|
46,749
|
$2,746,000 | — | 30 Sep 2021 |
Institutional Holders of Kymera Therapeutics, Inc. - COMMON STOCK (KYMR) as of Q4 2021
As of 31 Dec 2021,
Kymera Therapeutics, Inc. - COMMON STOCK (KYMR) was held by
123 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
43,015,870 shares.
The largest 10 holders included
Atlas Venture Life Science Advisors, LLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., BVF INC/IL, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, Redmile Group, LLC, BAKER BROS. ADVISORS LP, FMR LLC, and STATE STREET CORP.
This page lists
124
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
115
Q4 2021 holders
123
Holder diff
8
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 Value $ | Q4 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.